Characterisation of immune responses and protective efficacy in mice after immunisation with Rift Valley Fever virus cDNA constructs.
about
A Recombinant Rift Valley Fever Virus Glycoprotein Subunit Vaccine Confers Full Protection against Rift Valley Fever Challenge in SheepRapid screening for entry inhibitors of highly pathogenic viruses under low-level biocontainmentReverse genetics technology for Rift Valley fever virus: current and future applications for the development of therapeutics and vaccines.Vaccination with DNA plasmids expressing Gn coupled to C3d or alphavirus replicons expressing gn protects mice against Rift Valley fever virus.A replication-incompetent Rift Valley fever vaccine: chimeric virus-like particles protect mice and rats against lethal challengeRift Valley fever virus(Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and preventionAnti-nucleocapsid protein immune responses counteract pathogenic effects of Rift Valley fever virus infection in mice.Rift valley fever: recent insights into pathogenesis and preventionFunctional analysis of Rift Valley fever virus NSs encoding a partial truncation.The nucleocapsid protein of Rift Valley fever virus is a potent human CD8+ T cell antigen and elicits memory responsesTowards a safe, effective vaccine for Rift Valley fever virusAdvances in Rift Valley fever research: insights for disease preventionSingle-dose immunization with virus replicon particles confers rapid robust protection against Rift Valley fever virus challengeSingle-cycle replicable Rift Valley fever virus mutants as safe vaccine candidatesA single immunization with MVA expressing GnGc glycoproteins promotes epitope-specific CD8+-T cell activation and protects immune-competent mice against a lethal RVFV infection.Technical transformation of biodefense vaccines.Rift valley fever vaccines.A glycoprotein subunit vaccine elicits a strong Rift Valley fever virus neutralizing antibody response in sheep.Molecular detection of Rift Valley fever virus in serum samples from selected areas of Tanzania.Rift Valley fever virus structural and nonstructural proteins: recombinant protein expression and immunoreactivity against antisera from sheep.Virus-like particle-based countermeasures against Rift Valley fever virus.Current Status of Rift Valley Fever Vaccine Development.
P2860
Q26315336-D41CCDDF-DD2A-4DF9-B841-EB31579EABFAQ28731583-4F3A8C2C-76E5-4779-9187-E8F6ED3080DBQ33570326-21941ED0-A1D2-4A7A-8331-2B694490C396Q33617793-6C576950-6B77-43A4-A6AB-8A2FB072894EQ33621078-C5F60E8C-B712-4FF7-985B-5E90BE360213Q33960690-B6E2E58B-3A0F-4BBD-90DC-01BA223B5107Q34031858-9F01ECA8-E5BD-4939-9899-35E345476FC3Q34174444-67A56332-B19C-42A4-BB19-A10C087B8DC7Q34429914-69768BD8-A96F-4FCF-BD3D-D905471C18B0Q34634852-925C224E-E26E-4608-AAAE-84B7EC0D951CQ34677989-AD342995-52D3-4559-8B54-92FA528DC7A7Q35077969-94E0976B-97BA-4AA7-9D47-682CAE27AF8DQ35868079-60142B4B-40B8-49C6-81E4-675859D94E63Q36326847-64398024-3FA8-4BC6-AF96-12C903DA653DQ37004283-2F57284A-57A7-4528-A235-48992C9E2387Q37058898-D225BB12-EC14-4265-9C6D-3A396051C52FQ37393780-8F037300-8DFE-44B9-9BE2-1F9A18E81CF0Q40186455-001CB4B6-0C42-4B62-BEA8-4DC7A27A1B1FQ40220077-764519E0-3134-423B-A0BE-870D24C522D2Q40237478-50CFFF16-A345-4164-81EC-E38913E324EDQ40254473-0C3FB6CE-48F0-480A-B022-4F98BEA89723Q41929716-3CE298EC-B173-4401-B794-24BD9BDEFDD8
P2860
Characterisation of immune responses and protective efficacy in mice after immunisation with Rift Valley Fever virus cDNA constructs.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Characterisation of immune res ...... y Fever virus cDNA constructs.
@en
Characterisation of immune res ...... y Fever virus cDNA constructs.
@nl
type
label
Characterisation of immune res ...... y Fever virus cDNA constructs.
@en
Characterisation of immune res ...... y Fever virus cDNA constructs.
@nl
prefLabel
Characterisation of immune res ...... y Fever virus cDNA constructs.
@en
Characterisation of immune res ...... y Fever virus cDNA constructs.
@nl
P2093
P2860
P356
P1433
P1476
Characterisation of immune res ...... y Fever virus cDNA constructs.
@en
P2093
Ake Lundkvist
Göran Bucht
Jonas Näslund
Michèle Bouloy
Nina Lagerqvist
P2860
P356
10.1186/1743-422X-6-6
P577
2009-01-17T00:00:00Z